Daniela Schwarzenbacher
Graz, 8010, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
ALYREF, a novel factor involved in breast carcinogenesis, acts through transcriptional and post-transcriptional mechanisms selectively regulating the short NEAT1 isoform.
Journal: Cellular and molecular life sciences : CMLS
Published: December 01, 2021
Pharmacokinetics and Pharmacodynamics of Three Different Formulations of Insulin Aspart: A Randomized, Double-Blind, Crossover Study in Men With Type 1 Diabetes.
Journal: Diabetes care
Published: May 02, 2020
MiR-1287-5p inhibits triple negative breast cancer growth by interaction with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors.
Journal: Breast cancer research : BCR
Published: September 20, 2018
SOX9 is a proliferation and stem cell factor in hepatocellular carcinoma and possess widespread prognostic significance in different cancer types.
Journal: PloS one
Published: August 27, 2017
Current Status of Long Non-Coding RNAs in Human Breast Cancer.
Journal: International journal of molecular sciences
Published: July 27, 2016
KCNJ3 is a new independent prognostic marker for estrogen receptor positive breast cancer patients.
Journal: Oncotarget
Published: June 04, 2016
Current Insights into Long Non-Coding RNAs in Renal Cell Carcinoma.
Journal: International journal of molecular sciences
Published: February 22, 2016
miR-199a and miR-497 Are Associated with Better Overall Survival due to Increased Chemosensitivity in Diffuse Large B-Cell Lymphoma Patients.
Journal: International journal of molecular sciences
Published: July 12, 2015
Low spinophilin expression enhances aggressive biological behavior of breast cancer.
Journal: Oncotarget
Published: January 05, 2015
MiR-96-5p influences cellular growth and is associated with poor survival in colorectal cancer patients.
Journal: Molecular carcinogenesis
Published: June 22, 2014
NR4A1-mediated apoptosis suppresses lymphomagenesis and is associated with a favorable cancer-specific survival in patients with aggressive B-cell lymphomas.
Journal: Blood
Published: February 21, 2014
Last Updated: 09/26/2026